Conmed outlines 2026 revenue target of $1.345B–$1.375B while advancing portfolio focus and supply chain improvements [Seeking Alpha]
CONMED Corporation (CNMD)
Last conmed corporation earnings: 4/29 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
conmed.com/en/about-us/investors/investor-relations
Company Research
Source: Seeking Alpha
CEO Patrick Beyer emphasized that total sales for the quarter reached $373.2 million, reflecting a year-over-year increase of 7.9% as reported and 7.1% in constant currency. Full-year sales were $1.375 billion, with year-over-year growth of 5.2% as reported. Orthopedics Newsletters for Every Investor Get daily, sector-specific newsletters packed with expert insights, fresh ideas, and new opportunities. Subscribe to Newsletters Sign Up Quick Insights Management expects the GI exit to improve long-term consolidated gross margins by approximately 80 basis points once completed, despite near-term earnings dilution. The 2026 guidance is supported by growth in AirSeal, BioBrace, Buffalo Filter platforms, ongoing supply chain improvements, strengthening portfolios, share repurchases, and continued investments in innovation. Management noted a strong international Q4 but expressed caution about projecting Q1 performance, with analysts questioning the sustainability and manage
Show less
Read more
Impact Snapshot
Event Time:
CNMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CNMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CNMD alerts
High impacting CONMED Corporation news events
Weekly update
A roundup of the hottest topics
CNMD
News
- CONMED (NYSE:CNMD) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.MarketBeat
- CONMED (NYSE:CNMD) had its price target raised by analysts at Wells Fargo & Company from $41.00 to $42.00. They now have an "equal weight" rating on the stock.MarketBeat
- CONMED (NYSE:CNMD) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.MarketBeat
- Conmed Corp (CNMD) Q4 2025 Earnings Call Highlights: Strong Orthopedic Sales Drive Growth ... [Yahoo! Finance]Yahoo! Finance
- CONMED Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
CNMD
Earnings
- 1/28/26 - Beat
CNMD
Sec Filings
- 1/28/26 - Form 8-K
- 1/12/26 - Form 8-K
- 1/8/26 - Form 8-K
- CNMD's page on the SEC website